Drawing for ALLOSURE

USPTO serial 99410410

ALLOSURE

Reviewed by CopyMark Law Group

Reg. 8351449Status 700Registered
Filing date
Status date
Registration date
Jul 21, 2026
Examiner
BERNS, LEE ANNE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALLOSURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Theresa Conduah

Theresa Conduah Alston & Bird LLP350 South Grand Avenue, 51st FloorLos Angeles, CA 90071United States

Goods and services

ClassDescriptionStatusFirst use
042Providing temporary use of non-downloadable cloud based software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical records; Providing online, non-downloadable software for use in informing clinical patient management in the medical and health care fields; Providing online, non-downloadable software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Providing online, non-downloadable software for use in performing predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Providing online, non-downloadable software for managing an electronic medical record system; Providing online, non-downloadable software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Providing online, non-downloadable software for performing predictive analytics that include algorithms for use in the medical and healthcare fields; Providing online, non-downloadable software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Providing online, non-downloadable software that conducts predictive and risk analytics for use in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software for use in informing clinical patient management in the medical and health care fields; Providing temporary use of non-downloadable cloud based software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Providing temporary use of non-downloadable cloud based software for use in performing predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Providing temporary use of non-downloadable cloud based software for managing an electronic medical record system; Providing temporary use of non-downloadable cloud based software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Providing temporary use of non-downloadable cloud based software for performing predictive analytics that include algorithms for use in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software that conducts predictive and risk analytics for use in the medical and healthcare fields; Software as a service (SaaS) services featuring software for use in informing clinical patient management in the medical and health care fields; Software as a service (SaaS) services featuring software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Software as a service (SaaS) services featuring software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Software as a service (SaaS) services featuring software for managing an electronic medical record system; Software as a service (SaaS) services featuring software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Software as a service (SaaS) services featuring software for performing predictive analytics that include algorithms for use in the medical and healthcare fields; Software as a service (SaaS) services featuring software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Software as a service (SaaS) services featuring software that conducts predictive and risk analytics for use in the medical and healthcare fieldsACTIVEAug 14, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 21, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 7, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 7, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2026DOCKASSIGNED TO EXAMINER—
Feb 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 24, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance